KATELYN WHITE: Open Payments
NPI 1730661521 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 59 payments from 30 companies in 2025. Trend: 2023 $199 · 2024 $600 · 2025 $2,694
Food & beverage: $2,616Education: $78
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $542 |
| Janssen Biotech, Inc. | 7 | $434 |
| Incyte Corporation | 6 | $235 |
| Amgen Inc. | 2 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| PFIZER INC. | 1 | $125 |
| GENZYME CORPORATION | 1 | $122 |
| Astellas Pharma US Inc | 1 | $115 |
| Merck Sharp & Dohme LLC | 3 | $62 |
Products named: Padcev, RYBREVANT, ERLEADA, ENHERTU, Nubeqa, HYQVIA, TAGRISSO, CABLIVI.
Industry payments across TX — which companies pay providers there.
